Loading institutional data...
Loading institutional data...
Held by 221 of 5,944 reporting institutions (92th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
Solve the discounted cash flow backwards, then stress-test the assumptions.
This company doesn't have positive free cash flow, so a reverse DCF can't be run.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$65M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -23%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2024 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-09-17
Where each multiple sits in its own 6-yr range · 74th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | 152.7 | 92.0 | 72.9 | 73.4 | 90.0 | 63.6 | 50.7 |
| Gross Profit | -52.7 | 8.0 | 27.1 | 26.6 | 10.0 | 36.4 | 49.3 |
| R&D | 204.1 | 123.3 | 103.0 | 156.8 | 109.5 | 52.3 | 38.5 |
| SG&A | 127.5 | 110.9 | 154.7 | 149.2 | 98.4 | 52.8 | 38.2 |
| Operating Income | -423.8 | -273.8 | -297.0 | -354.4 | -448.1 | -93.8 | -43.7 |
| Income Tax | 0.0 | 2.0 | -8.3 | 0.7 | 0.6 | 0.5 | -1.7 |
| Net Income | -452.7 | -564.9 | -279.9 | -337.7 | -449.2 | -87.3 | -35.6 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on OUST: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $169.4M 100.0% | $111.1M 100.0% | $83.3M 100.0% | $41.0M 100.0% | $33.6M 100.0% | $18.9M 100.0% | $11.4M 100.0% |
| Cost of Revenue | $85.9M 50.7% | $70.6M 63.6% | $75.0M 90.0% | $30.1M 73.4% | $24.5M 72.9% | $17.4M 92.0% | $17.4M 152.7% |
| Gross Profit | $83.4M 49.3% | $40.5M 36.4% | $8.3M 10.0% | $10.9M 26.6% | $9.1M 27.1% | $1.5M 8.0% | -$6.0M -52.7% |
| Research & Development | $65.2M 38.5% | $58.1M 52.3% | $91.2M 109.5% | $64.3M 156.8% | $34.6M 103.0% | $23.3M 123.3% | $23.3M 204.1% |
| Selling, General & Admin | $64.6M 38.2% | $58.7M 52.8% | $82.0M 98.4% | $61.2M 149.2% | $52.0M 154.7% | $21.0M 110.9% | $14.5M 127.5% |
| Total Operating Expenses | $157.4M 92.9% | $144.6M 130.2% | $381.5M 458.1% | $156.4M 381.1% | $108.8M 324.0% | $53.3M 281.8% | $42.3M 371.1% |
| Operating Income | -$74.0M -43.7% | -$104.2M -93.8% | -$373.2M -448.1% | -$145.4M -354.4% | -$99.7M -297.0% | -$51.8M -273.8% | -$48.4M -423.8% |
| Interest Expense | $0 0.0% | $1.8M 1.6% | $9.3M 11.2% | $2.7M 6.6% | $504K 1.5% | $2.5M 13.3% | $3.6M 31.4% |
| Interest & Investment Income | $9.5M 5.6% | $8.8M 8.0% | $9.0M 10.9% | $2.2M 5.4% | $471K 1.4% | $24K 0.1% | $278K 2.4% |
| Other Income (Expense), net | $10.7M 6.3% | $7.7M 6.9% | -$395K -0.5% | $7.2M 17.5% | $2.9M 8.7% | -$54.6M -289.1% | -$3.3M -28.9% |
| Pretax Income | -$63.3M -37.4% | -$96.5M -86.9% | -$373.6M -448.6% | -$138.3M -337.0% | -$96.8M -288.2% | -$106.4M -562.9% | -$51.7M -452.6% |
| Income Tax Expense | -$2.9M -1.7% | $537K 0.5% | $523K 0.6% | $305K 0.7% | -$2.8M -8.3% | $375K 2.0% | $1K 0.0% |
| Net Income | -$60.4M -35.6% | -$97.0M -87.3% | -$374.1M -449.2% | -$138.6M -337.7% | -$94.0M -279.9% | -$106.8M -564.9% | -$51.7M -452.7% |
| Per Share | |||||||
| EPS (Basic) | $-1.07 | $-2.08 | $-10.10 | $-7.79 | $-0.70 | $-5.98 | $-6.99 |
| EPS (Diluted) | $-1.07 | $-2.08 | $-10.10 | $-7.79 | $-0.70 | $-5.98 | $-6.99 |
| Weighted Avg Shares (Basic) | 56.3M | 46.6M | 37.0M | 17.8M | 133.9M | 17.9M | 7.4M |
| Weighted Avg Shares (Diluted) | 56.3M | 46.6M | 37.0M | 17.8M | 133.9M | 17.9M | 7.4M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 743 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TSM | $11.16T | — | — | — | — | — | — | — | — | — | 3,121 |
| NVDA | $5.33T | 44.8× | 40.0× | 24.7× | 65.5% | 71.1% | 55.6% | 76.3% | 72.4% | 0.1× | 5,582 |
| AAPL | $4.98T | 45.2× | 34.8× | 12.0× | 6.4% | 46.9% | 26.9% | 152% | 68.1% | 0.6× | 5,858 |
| MSFT | $3.70T | 27.7× | 19.6× | 11.1× | 17.8% | 67.9% | 40.3% | 30.2% | 27.7% | 0.2× | 5,944 |
| AVGO | $1.65T | 72.8× | 65.1× | 25.8× | 23.9% | 67.8% | 36.2% | 28.4% | 15.8% | 2.5× | 4,442 |
| MU | $1.10T | 128.8× | 60.7× | 29.3× | 48.9% | 39.8% | 22.8% | 15.8% | 12.9% | 0.7× | 2,894 |
| AMD | $888.5B | 205.7× | 210.2× | 25.6× | 34.3% | 49.5% | 12.5% | 6.9% | 6.5% | 0.8× | 3,059 |
| INTC | $543.3B | — | 67.4× | 10.3× | -0.5% | 34.8% | -0.5% | -0.2% | -0.2% | 5.5× | 2,495 |
| CSCO | $436.6B | 43.2× | 36.6× | 7.7× | 5.3% | 64.9% | 18.0% | 21.7% | 13.6% | 2.3× | 3,560 |
| PLTR | $421.4B | 279.8× | 291.6× | 94.2× | 56.2% | 82.4% | 36.3% | 22.0% | 22.0% | — | 2,883 |
| DELL | $383.6B | 67.8× | 36.1× | 3.4× | 18.8% | 20.0% | 5.2% | -240% | 20.4% | 2.8× | 1,564 |
| LRCX | $341.7B | 64.9× | 54.5× | 18.5× | 23.7% | 48.7% | 29.1% | 54.3% | 37.4% | 0.7× | 2,500 |
| RPAY | $338.0B | — | — | 1092.8× | -1.2% | 75.0% | -83.0% | -53.0% | -28.2% | -1.7× | 142 |
| AMAT | $331.0B | 48.2× | 38.1× | 11.7× | 4.4% | 48.7% | 24.7% | 34.3% | 25.9% | 0.8× | 2,826 |
| UMC | $307.4B | — | — | — | — | — | — | — | — | — | 302 |
| ARM | $281.9B | 311.6× | 242.9× | 57.3× | 22.8% | 97.5% | 18.4% | 10.9% | 10.9% | — | 730 |
| SAP | $262.5B | — | — | — | — | — | — | — | — | — | 794 |
| ANET | $250.7B | 72.6× | 63.3× | 27.8× | 28.6% | 64.1% | 39.0% | 28.4% | 28.4% | — | 1,930 |
| PANW | $250.5B | 234.4× | 156.5× | 27.2× | 14.9% | 73.4% | 12.3% | 14.5% | 14.5% | — | 2,374 |
| SNDK | $235.7B | — | — | 32.0× | 10.4% | 30.1% | -22.3% | -17.8% | -14.8% | -1.5× | 1,127 |
| TXN | $234.6B | 47.4× | 30.9× | 13.3× | 13.0% | 57.0% | 28.3% | 30.7% | 16.5% | 1.8× | 2,345 |
| CRM | $225.6B | 31.1× | 24.4× | 5.4× | 9.6% | 77.7% | 18.0% | 12.6% | 10.1% | 1.5× | 2,547 |
| IBM | $222.8B | 21.3× | — | 3.3× | 7.6% | 58.2% | 15.7% | 32.4% | 11.3% | — | 3,351 |
| MRVL | $204.0B | 78.4× | 133.3× | 24.9× | 42.1% | 51.0% | 32.6% | 18.7% | 14.2% | 2.9× | 1,477 |
| QCOM | $202.7B | 37.7× | 15.2× | 4.6× | 13.7% | 55.4% | 12.5% | 26.1% | 15.4% | 1.1× | 2,611 |
| OUST | $2.1B | — | — | 12.6× | 52.5% | 49.3% | -35.6% | -23.1% | -23.1% | — | 221 |
Peers = companies sharing OUST's sector (Technology) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.